Lexicon Pharmaceuticals
LXRX
#7493
Rank
NZ$0.69 B
Marketcap
NZ$1.93
Share price
-19.44%
Change (1 day)
41.15%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): NZ-$0.34

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.32. In 2024 the company made an earnings per share (EPS) of NZ-$1.06 an increase over its 2023 EPS that were of NZ-$1.33.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.34-68.42%
2024NZ-$1.06-20%
2023NZ-$1.3331.15%
2022NZ-$1.01-0%
2021NZ-$1.0110.91%
2020NZ-$0.91-145.08%
2019NZ$2.03-206.09%
2018NZ-$1.91-5.74%
2017NZ-$2.03-10.95%
2016NZ-$2.272640%
2015NZ-$0.08302-96.34%
2014NZ-$2.27-2.53%
2013NZ-$2.32-9.09%
2012NZ-$2.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$28.79-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.42-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$72.13-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$9.86 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$3.97-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.83 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.25 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.52-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$127.37 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA